Sirona Biochem Corp V.SBM

Suspicion

[lscfa]

Is co. pumping out vague NRs in order to do a financing before fins at end of Sept reveal disappointing upfront payment from Abbvie?

[forhandlaren]

Any move is possible, but I lean towards the promised transparency as the main drive here. There was actually valuable information in the last NR. We got a pretty good status report. I think the anti-aging clinicals should kick off not later than September.

[MirrorWorldMan]

Interesting that Howie wants to attract Institutional investors as well.  The insti's will not buy on the open market and likely will receive a placement, which is what Howie would like based upon his desire to continually dilute and raise funds for the coffers.  The hidden issue is  why would he want to dilute if the Abbvie deal is so lucrative? Shouldn't the deal provide

[biorun]

to pick these guys up, the price needs to trade higher than a buck. there are only two ways. so that is obviously the plan, and especially if further  deals are announced and the financial profile of the abbvie deal provides a sustainable financial stream to grow other pipelines.  the other way is a reverse consolidation 3-4 to 1 or more. I don't think they lean that way personally